Sawai Hideaki, Oka Kaname, Ushioda Mariko, Nishimura Gen, Omori Takashi, Numabe Hironao, Kosugi Shinji
Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.
Genetic Counsellor Course, Kyoto University School of Public Health, Kyoto, Japan.
Pediatr Int. 2019 Aug;61(8):748-753. doi: 10.1111/ped.13927. Epub 2019 Aug 27.
Thanatophoric dysplasia (TD) is a rare congenital disease of the skeletal system, with an incidence of 1.68-8.3 per 100 000 births, but statistical data on the estimated number of TD patients across Japan are not available. The aim of this study was therefore to investigate the prevalence and prognosis of TD in Japan.
A nationwide primary questionnaire survey was conducted.
A total of 127 obstetric, 186 pediatric, and 115 orthopedic facilities provided responses. Excluding duplications, we identified 73 patients with TD. Of the 73 cases, 15 were abortions, four were stillbirths, 51 were live births, and three had unknown details. Of the 51 live newborns, 27 died ≤7 days after birth, with an early neonatal mortality rate of 56%. Of the 24 newborns who survived the early neonatal period, 16 survived for ≥1 year. All of the 24 newborns received respiratory management and survived during the early neonatal period. Of the 51 live newborns, 25 did not receive respiratory management and died ≤2 days after birth.
The prevalence of TD in Japan is estimated to be at 1.1 (95%CI: 0.84-1.37) per 100 000 births, but the actual incidence is expected to be higher. To our knowledge, we have confirmed for the first time that newborns with TD may not always die during the early neonatal period but can survive the early neonatal period with appropriate respiratory management. Therefore, the term "thanatophoric dysplasia" does not accurately reflect the nature of the disease.
致死性骨发育不全(TD)是一种罕见的先天性骨骼系统疾病,每10万例出生中发病率为1.68 - 8.3例,但日本全国TD患者估计数量的统计数据并不存在。因此,本研究的目的是调查日本TD的患病率和预后情况。
进行了一项全国范围的初步问卷调查。
共有127家产科机构、186家儿科机构和115家骨科机构提供了回复。排除重复病例后,我们确定了73例TD患者。在这73例病例中,15例为流产,4例为死产,51例为活产,3例情况不明。在51例活产新生儿中,27例在出生后≤7天死亡,早期新生儿死亡率为56%。在24例度过早期新生儿期的新生儿中,16例存活≥1年。所有24例新生儿均接受了呼吸管理并在早期新生儿期存活。在51例活产新生儿中,25例未接受呼吸管理并在出生后≤2天死亡。
日本TD的患病率估计为每10万例出生中有1.1例(95%置信区间:0.84 - 1.37),但实际发病率预计更高。据我们所知,我们首次证实TD新生儿并非总是在早期新生儿期死亡,而是通过适当的呼吸管理可以在早期新生儿期存活。因此,“致死性骨发育不全”这一术语并不能准确反映该疾病的本质。